The cachexia of malignancy is considered mediated through excess production of tumor necrosis factor–alpha and other cytokines. Thalidomide (Thalomid), a sedative/hypnotic, has been shown to inhibit tumor necrosis factor–alpha production.
G. Deck
Advertisement
Articles by G. Deck
Advertisement
Latest Updated Articles
- Thalidomide-Induced Cessation of Weight Loss and Improved Sleep in Advanced Cancer Patients With Cachexia
Published: November 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
4
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
5
